Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.

@article{Prenner2010MometasoneFN,
  title={Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.},
  author={Bruce M. Prenner and Bobby Quentin Lanier and David I. Bernstein and Tulin Shekar and Ariel A Teper},
  journal={The Journal of allergy and clinical immunology},
  year={2010},
  volume={125 6},
  pages={1247-1253.e5}
}
BACKGROUND Mometasone furoate nasal spray (MFNS), a potent intranasal corticosteroid with proved efficacy in relieving nasal allergic rhinitis symptoms, has demonstrated effectiveness in improving ocular symptoms associated with seasonal allergic rhinitis (SAR) in retrospective analyses. OBJECTIVE We sought to evaluate prospectively the efficacy of MFNS in reducing total ocular symptom scores (TOSSs) and individual ocular symptoms in subjects with SAR. METHODS Subjects 12 years or older (n… CONTINUE READING